Skip Navigation

Cardiovascular Research 2003 59(2):328-338; doi:10.1016/S0008-6363(03)00366-3
© 2003 by European Society of Cardiology
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schram, G.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schram, G.
Right arrow Articles by Nattel, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents

Gernot Schrama,b, Marc Pourriera,d, Zhiguo Wanga,b, Michel Whitea,b and Stanley Nattela,b,c,*

aDepartment of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8
bDepartment of Medicine, University of Montreal, Montreal, Quebec, Canada
cDepartment of Pharmacology, McGill University, Montreal, Quebec, Canada
dDepartment of Pharmacology, University of Montreal, Montreal, Quebec, Canada

* Corresponding author. Tel.: +1-514-376-3330; fax: +1-514-376-1355. nattel{at}icm.umontreal.ca

Received 14 January 2003; accepted 27 March 2003


    Abstract
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
Background: Kir2 subunits are believed to underlie the cardiac inwardly rectifying current IK1. The subunit composition of native IK1 currents is uncertain, and it has been suggested that heteromultimer formation may play a role. Methods: We studied Ba2+ block of homo- and heteromeric Kir2 channels in Xenopus oocytes and compared the properties observed to those of human cardiac IK1 in cells isolated from myocardial biopsies of normal human hearts. Results: Homomeric expression of Kir2.1 and Kir2.3 produced currents with similar Ba2+ sensitivities (e.g. IC50 at –120 mV: 16.2±3.4, n = 11 and 18.5±2.1, n = 10, respectively), but these were less sensitive to Ba2+ than native IK1 (4.7±0.5 µM, n = 10, P = 0.001, P<0.001, respectively) and had different Ba2+ blocking kinetics from cardiac IK1. Kir2.2 sensitivity was similar to cardiac IK1 (e.g., 2.8±0.4 µM, Kir2.2, n = 9, vs. 4.7±0.5 µM for IK1), but the blocking kinetics of Kir2.2 were faster than those of IK1. Currents resulting from co-expression of Kir2 subunits had similar Ba2+ sensitivities and blocking kinetics among groups and were similar to IK1 in both Ba2+ sensitivity (e.g., IC50 at –120 mV: 4.5±1.0, 2.5±0.5, and 2.3±0.4 µM for co-injected Kir2.1/2.2, n = 6, Kir2.1/2.3, n = 5, and Kir2.2/2.3, n = 4, respectively) and blocking kinetics. Conclusion: Co-injection of Kir2 subunits results in currents with Ba2+ blocking properties different from homomeric Kir2 expression but similar to cardiac IK1. These observations suggest that a substantial proportion of native IK1 may result from heteromultimer formation among diverse Kir2 family subunits.

KEYWORDS Ion transport; K-channel; Arrhythmia (mechanisms); Ion channels; Sudden death


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
The inward rectifier current (IK1) was first described in 1949 in skeletal muscle [1]. In the heart, IK1 sets the resting potential close to the K+ equilibrium potential [2] and contributes significantly to cardiac repolarization [3–5]. Dysfunction of IK1 causes cardiac arrhythmias in Andersen's syndrome (LQT7) [6].

A variety of genes encoding inwardly rectifying K+ (Kir) channel subunits has been cloned and grouped into seven families (Kir1–7). Subunits of the Kir2 family are believed to underlie IK1 in the heart [2]. Three pore-forming {alpha}-subunits of the Kir2 family, Kir2.1–3, are expressed in cardiomyocytes [7]. In the human heart, Kir2.1 transcripts are 10-fold more abundant than those of Kir2.2 or Kir2.3 [8]. The relative expression of Kir2 transcripts fails to explain a variety of cardiac IK1 properties [8]. Heteromultimer formation among Kir2 subunits results in currents distinct from those produced by homomeric Kir2 subunit expression [9,10], potentially contributing to phenotypic diversity in Andersen's syndrome [9]. However, no study in the literature has compared directly currents carried by homomeric and heteromeric Kir2 channels to native IK1.

High-potency block by extracellular Ba2+ is a striking pharmacological property of IK1 [10]. Kir2-based channels have different sensitivities to Ba2+ [7,9–11]. The goal of the present study was to compare Ba2+-blocking properties of currents carried by single Kir2 subunits with currents carried by co-expressed subunits and with human cardiac IK1.


    2. Methods
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
2.1 Functional expression of cloned inward rectifier subunits in Xenopus oocytes
Kir2.1 and Kir2.2 were subcloned into a modified expression vector (pCRII, Invitrogen) containing a poly (A+) tail (A+-pCRII). Kir2.1-A+-pCRII was a kind gift of Lily Leh Jan, San Francisco, CA, USA. Kir2.2-A+-pCRII was a kind gift of Barbara Wible, Cleveland, OH, USA. After linearization with BamHI, cRNA for injection into Xenopus oocytes was prepared with T7 RNA polymerase. Kir2.3 was a kind gift of Carol Vandenberg, Santa Barbara, CA, USA. Kir2.3 cDNA was subcloned into a Bluescript SK- (Stratagene) vector. After linearization with HindIII, cRNA was prepared with T3 RNA polymerase, and 6 to 12 ng cRNA of either a single clone or a mixture of equal amounts of different cRNAs (two at a time) to a total amount of 6 to 12 ng were injected into stage IV–V Xenopus oocytes, followed by two-electrode voltage-clamp 24–72 h later. Currents were elicited at 22°C by 750-ms voltage steps from a holding potential of –60 mV to test potentials between –150 mV and +30 mV in 10 mV increments with a GeneClamp-500 amplifier and pClamp 6.0 software (Axon Instruments). The external solution consisted of (mM) 5 KCl, 100 NaCl, 2 MgCl2, 10 HEPES, 0.3 CaCl2. Niflumic acid (10 µM) was added to block the Ca2+-dependent Cl current. The external pH was adjusted to 7.4 with NaOH and the pipette was filled with 3 M KCl. Ba2+-containing solutions were superfused until steady-state block occurred (generally after ~10 min) at each concentration before repeating full voltage-clamp protocols. Glass microelectrodes (3 M KCl-filled) had 1.3–1.8 M{Omega} resistances. All cRNA transcriptions were performed with the mMESSAGE mMACHINE kit (Ambion Inc., Austin, TX, USA).

2.2 Cell isolation
Human right ventricular myocytes were obtained via endomyocardial biopsies from patients undergoing routine follow-up after heart transplantation. Ca2+-tolerant myocytes were isolated and stored for use within 12 h according to previously-described procedures [8]. Written informed consent was obtained as approved by the Ethics Committee of the Montreal Heart Institute. Cells were dispersed by trituration with a Pasteur pipette and stored in a high K+-storage medium (in mM: KCl 20, K-glutamate 70, KH2PO4 10, glucose 25, β-hydroxybutyric acid 10, taurine 20, EGTA 10, albumin 0.1%, and mannitol 40) at 4°C. All chemicals were purchased from Sigma Chemical Co., St Louis, MO, USA, unless otherwise specified.

2.3 Whole-cell patch-clamp recordings
Experiments were conducted at 22°C and ionic currents were recorded under whole-cell voltage-clamp mode using an Axopatch 200B amplifier (Axon Instruments). Borosilicate glass electrodes (1 mm O.D.) had tip resistances of 2–4 M{Omega} when filled with pipette solution (mM): 0.1 GTP, 110 K-aspartate, 20 KCl, 1 MgCl2, 5 Mg–ATP, 10 HEPES, 5 EGTA, 5 Na2-phosphocreatine. The pH was adjusted to 7.4 with NaOH. Command pulses were generated by a D–A converter controlled by pClamp 6.05 software (Axon Instruments). Tip potentials were zeroed before formation of the membrane–pipette seal in Tyrode solution. The capacitance and series resistance (Rs) were electrically compensated to minimize the duration of the capacitive surge on the current recording and the voltage drop across the clamped cell membrane. 200 µM Cd2+, 500 µM 4-aminopyridine (4-AP) and 1 µM atropine were added to the extracellular solution to inhibit current contamination by L-type Ca2+-current, transient outward K+-current and acetylcholine-dependent K+-current, respectively. Adenosine triphosphate (ATP)-dependent K+-current was minimized by including ATP (Mg-salt, 5 mM) in the pipette and glyburide (10 µM) in the bath solution.

2.4 Statistical analysis
Data analysis was conducted with Axon Clampfit 6, SPSS 11, Graphpad Prism 3 and Microsoft Excel 2000. Group data are expressed as the mean±S.E.M. Statistical comparisons were made with one-way ANOVA followed by Tukey's post-test (SPSS 11). A two-tailed probability P<0.05 was taken to indicate statistical significance. Concentration–response data were analyzed using curve-fitting functions of Prism 3 software (GraphPad Software Inc. CA, USA).


    3. Results
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
Fig. 1 shows original recordings in oocytes injected with Kir2.1 (A), Kir2.2 (B) or Kir2.3 (C) cRNA and from a human cardiomyocyte (D). Left panels show currents recorded in the absence of Ba2+ (Control). Left middle panels, right middle panels and right panels show currents in the presence of 10 µM, 100 µM and 1 mM Ba2+, respectively. Ba2+-block was concentration- and voltage-dependent for all currents. Fig. 2 shows respective Kir2 mean end-pulse current–voltage relationships under control conditions and in the presence of 1, 10 and 100 µM Ba2+. Kir2.1 and Kir2.3 showed similar Ba2+-sensitivity, with high-level block requiring 100 µM Ba2+. Both Kir2.2 and cardiac IK1 were reduced by >60% with 10 µM Ba2+ and completely blocked by 100 µM Ba2+, indicating qualitatively-similar sensitivity that was greater than that of Kir2.1 or Kir2.3.


Figure 1
View larger version (27K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1 Original current recordings obtained from oocytes injected with Kir2.1 (A), Kir2.2 (B) or Kir2.3 (C) and from human right ventricular myocytes (D) under control conditions (left panels) and in the presence of 10 µM (left middle panels), 100 µM (right middle panels) and 1 mM (right panels) Ba2+. Kir2 currents were elicited by voltage steps from a holding potential of –60 mV to step potentials between –150 mV and +30 mV in 10 mV increments as shown by the voltage protocol in the inset. IK1 was elicited by voltage steps from a holding potential of 0 mV to step potentials between –120 mV and +40 mV in 10 mV increments as shown by the voltage protocol in the inset.

 

Figure 2
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2 Mean±S.E.M. of current–voltage relations under steady-state conditions without drug (Control, squares) and in the presence of 1, 10 and 100 µM Ba2+ (triangles, circles and diamonds, respectively). n = 14, 9, 11 and 10 cells for Kir2.1 (A), Kir2.2 (B), Kir2.3 (C) and cardiac IK1 (D).

 
Fig. 3 shows original current recordings obtained from Xenopus oocytes co-injected with both Kir2.1 and Kir2.2 (A), Kir2.1 and Kir2.3 (B) or Kir2.2 and Kir2.3 (C) cRNA, as well as current recordings from a ventricular myocyte (D), under control conditions (left panels) and in the presence of 10, 100 µM and 1 mM Ba2+. The response of co-injected oocytes was qualitatively like that of the human cardiomyocyte. Corresponding mean current–voltage relationships are shown in Fig. 4. The current–voltage relationships of co-injected oocytes qualitatively resemble those of cardiac IK1 in both the absence of Ba2+ and in the presence of various Ba2+ concentrations. The Ba2+-sensitivity of homomeric channels and channels resulting from co-injected Kir2 subunits showed significant group differences over the entire voltage range tested (–150 to –90 mV, P<0.001).


Figure 3
View larger version (31K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 3 Original current recordings obtained from oocytes co-injected with Kir2.1/Kir2.2 (A), Kir2.1/Kir2.3 (B) or Kir2.2/2.3 (C) and from a human right ventricular myocyte (D) under control conditions (left panels) and in the presence of 10 µM (left middle panels), 100 µM (right middle panels) and 1 mM (right panels) Ba2+. Kir2 currents were elicited by voltage steps from a holding potential of –60 mV to step potentials between –150 mV and +30 mV in 10 mV increments, as shown by the voltage protocol in the inset. IK1 was elicited by voltage steps from a holding potential of 0 mV to test potentials between –120 mV and +40 mV in 10 mV increments, as shown by the voltage protocol in the inset.

 

Figure 4
View larger version (20K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 4 Mean±S.E.M. of current–voltage relations under steady-state conditions without drug (control, squares) and in the presence of 1, 10 and 100 µM Ba2+ (triangles, circles and diamonds, respectively). n = 7, 6, 4 and 10 cells for Kir2.1/Kir2.2 (A), Kir2.1/Kir2.3 (B), Kir2.2/Kir2.3 (C) and cardiac IK1 (D).

 
3.1 Concentration and time dependence of Ba2+ block of homomeric Kir2 subunits and cardiac IK1
To pursue the issue of Ba2+-block of the various constructs studied, we analyzed the block quantitatively. Fig. 5, left panels, shows original currents recorded from one oocyte before and after each of three Ba2+ concentrations for cells expressing Kir2.1 (A), Kir2.2 (B) or Kir2.3 (B), along with corresponding data from a human cardiomyocyte (D). For clarity, currents obtained at only one voltage (upon hyperpolarization to –120 mV) are shown. Whereas Kir2.1 and Kir2.3 showed similar Ba2+ sensitivity (approximately 30% current reduction at end of pulse by 10 µM Ba2+, Fig. 5A and C), Kir2.2 was approximately one order of magnitude more sensitive to Ba2+ than Kir2.1 or Kir2.3. For example, 10 µM Ba2+ almost completely inhibited Kir2.2 end-pulse current (Fig. 5B, left), similar to the effect of 100 µM Ba2+ on Kir2.1 (Fig. 5A, left) or Kir2.3 (Fig. 5C, left). Cardiac IK1 was more sensitive to Ba2+ than Kir2.1 or Kir2.3 (e.g., approximately 70% end-pulse current inhibition by 10 µM Ba2+, Fig. 5D, left), displaying Ba2+-sensitivity more similar to that of Kir2.2.


Figure 5
View larger version (40K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 5 Ba2+-block of currents resulting from the expression of Kir2.1 (A), Kir2.2 (B), Kir2.3 (C) and human ventricular IK1 (D). Left panels show original recordings obtained from one oocyte under control conditions and in the presence of 1, 10 and 100 µM Ba2+. Currents were elicited by steps from a holding potential of –60 mV to –120 mV in oocytes and by steps from 0 mV to –120 mV in myocytes, as shown in the protocols in the insets. Kinetics of Ba2+ block in the same oocyte or myocyte, respectively, are shown as fractional block in the middle panels. Fractional block was calculated as control current (ICtl) minus current in the presence of Ba2+ (IBa) divided by control current ([ICtlIBa]/ICtl). The positions of the t1/2s for each example are shown by arrows. The right panels show corresponding mean±S.E.M. concentration–response curves based on end-pulse block at each concentration upon hyperpolarization to –120 mV (n = 11, 9, 10 and 10 cells for Kir2.1, Kir2.2, Kir2.3 and cardiac IK1, respectively).

 
The time-dependence of block is illustrated in the middle column of Fig. 5. Fractional block was calculated as control current (ICtl) minus current in the presence of Ba2+ (IBa) divided by control current ([ICtlIBa]/ICtl), and expressed as a function of time during the pulse. For Kir2.1 and 2.3, block at 10 µM was virtually time-independent. At the same concentration, block of Kir2.2 showed a very rapid onset. The time-dependent block of cardiac IK1 was substantial at 10 µM and showed a slow onset. The onset of Ba2+ block was quantified as the time for 50% of steady-state time-dependent block (t1/2), since the kinetics did not consistently follow simple mono- or biexponential models. Block onset was analyzed at approximately equi-effective concentrations (10 µM for Kir2.2 and IK1, 100 µM for Kir2.1 and 2.3). The t1.2 values of homomeric constructs were smaller than the value for IK1 (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1 Potency and time-course of Ba2+ block of various constructs

 
The right panels show mean concentration–response curves of the form B = 1/(1+IC50/C), where B is Ba2+-block at any concentration C and IC50 is the 50% blocking concentration. The Ba2+ IC50s were comparable for Kir2.1 and 2.3 (16.2±3.6 and 18.5±2.1 µM respectively), about an order of magnitude greater than for Kir2.2 (2.3±0.4 µM). Cardiac IK1 had an IC50 (4.7±0.4 µM) of the same order as that of Kir2.2 and much smaller than for Kir2.1 or 2.3 (Table 1).

3.2 Concentration and time dependence of Ba2+-block of co-injected Kir2 subunits and cardiac IK1
Fig. 6, left panels show original current recordings obtained from Xenopus oocytes co-injected with either Kir2.1/Kir2.2 (A), Kir2.1/Kir2.3 (B) or Kir2.2/Kir2.3 (C), in comparison with human cardiac IK1 (D), upon hyperpolarization to –120 mV. Currents resulting from co-injected Kir2 subunits showed qualitatively similar Ba2+-sensitivity to cardiac IK1. The middle column shows time-dependent block onset. Like IK1, block of Kir2.1/Kir2.2 and Kir2.1/2.3 showed significant, slow time-dependent onset at 10 µM Ba2+. The t1/2 values for Kir2.1/2.2 and Kir2.1/2.3 co-injected were similar to those of IK1 (Table 1). The t1/2 was somewhat faster for Kir2.2/2.3 subunits. The corresponding concentration–response relations are shown in the right column. In contrast to the homomeric subunit-based currents, the currents resulting from co-injection showed similar and low IC50s (Table 1). This was the case even for Kir2.1/Kir2.3 currents, despite the fact that both Kir2.1 and Kir2.3 had much higher IC50s when expressed alone. The IC50s for all co-injected subunit combinations were comparable to the values for IK1.


Figure 6
View larger version (40K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 6 Ba2+ block of currents resulting from the co-expression of Kir2.1/Kir2.2 (A), Kir2.1/Kir2.3 (B), Kir2.2/Kir2.3 (C) and human ventricular IK1 (D). Left panels show original recordings obtained from one oocyte under control conditions and in the presence of 1, 10 and 100 µM Ba2+. Currents were elicited by steps from a holding potential of –60 mV to –120 mV in oocytes and by steps from 0 mV to –120 mV in myocytes, as shown in the protocol in the inset. Kinetics of Ba2+-block in the same oocyte or myocyte, respectively, are shown as fractional block in the right panels. Fractional block was calculated as control current (ICtl) minus current in the presence of Ba2+ (IBa) divided by control current ([ICtlIBa]/ICtl). The positions of the t1/2s are indicated by arrows in the middle panels. The right panels show corresponding mean±S.E.M. concentration–response curves based on end-pulse block at each concentration upon hyperpolarization to –120 mV (n = 7, 6, 4 and 10 cells for Kir2.1, Kir2.2, Kir2.3 and cardiac IK1, respectively).

 
3.3 Comparison of Ba2+ blocking properties of homomeric and co-injected Kir2 subunits with cardiac IK1
Fig. 7 shows a comparison of block at –120 mV for each pair of co-injected Kir2 subunits with that of IK1 (middle panels) and for each of the corresponding homomeric currents with IK1 (left panels). The right panels show Ba2+ IC50 values as a function of voltage for each of the corresponding currents. The asterisks in the right panels show the statistical significance of differences for blocking potency at each voltage versus that of IK1. For Kir2.1 and 2.2 (A), block is less potent for Kir2.1 and more potent for Kir2.2 at –120 mV compared to cardiac IK1 (left panel). Block of Kir2.1/2.2 co-injected currents at –120 mV is quite similar to that of IK1 (middle). Comparing results at all voltages (right panels), results for Kir2.1 were significantly different from those of IK1. Results for Kir2.2, 2.1/2.3 and IK1 were not statistically distinguishable. For Kir2.1 and 2.3 (panel B), either homomer resulted in currents less sensitive to Ba2+ than IK1 (left panel), but co-injected oocytes showed a sensitivity comparable to that of IK1 (middle panel). Examining the entire voltage range, homomeric Kir2.1 and 2.3 were each significantly less sensitive than currents resulting from Kir2.1/2.3 co-injection, which were indistinguishable from IK1 (right). The corresponding data for Kir2.2 and 2.3 (C) indicates that once again co-injected oocytes have currents with Ba2+-sensitivity similar to that of IK1.


Figure 7
View larger version (39K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 7 Comparison of mean±S.E.M. concentration–response curves based on end-pulse block at each concentration at a test potential of –120 mV. Left panels compare Ba2+ block of currents carried by homomeric Kir2 channels with cardiac IK1. Heteromeric channels composed of subunits shown in left panels are compared to cardiac IK1 in the middle panels. Right panels: comparison of homomeric and heteromeric Kir2 and cardiac IK1 mean Ba2+ IC50s at test potentials between –120 mV and –90 mV. *P<0.05, **P<0.01, ***P<0.001 versus cardiac IK1 at the same voltage. (A) left panels: Kir2.1, Kir2.2 and cardiac IK1 (open squares, open circles and filled diamonds, respectively; n = 11, 9 and 10 cells for Kir2.1, Kir2.2 and cardiac IK1). Middle panels: Kir2.1/Kir2.2 (open diamonds, n = 7) and cardiac IK1 (filled diamonds; n = 10). (B) left panels: Kir2.1 (open squares, n = 11), Kir2.3 (filled circles, n = 10) and cardiac IK1 (filled diamonds, n = 10). Middle panels: Kir2.1/Kir2.3 (open diamonds, n = 6) and cardiac IK1 (filled diamonds, n = 10). (C) left panels: Kir2.2 (open circles, n = 9), Kir2.3 (filled circles, n = 10) and cardiac IK1 (filled diamonds, n = 10). Middle panels: Kir2.2/Kir2.3 (open diamonds, n = 4) and cardiac IK1 (filled diamonds, n = 10).

 

    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
We have compared the Ba2+-blocking response of currents carried by homomeric channels composed of Kir2.1, Kir2.2 and Kir2.3 with the response of currents resulting from co-expressed subunits and with human cardiac IK1. The principle novel findings are that the response of co-expressed subunit-currents is not the simple algebraic sum of individual subunit responses, and that the response of native human IK1 is more similar to that of co-injected subunits than of each subunit expressed alone.

4.1 Importance and molecular basis of IK1
IK1 is crucial in cardiac electrophysiology [2,11], setting the resting potential and contributing to terminal repolarization [5]. Resting potential depolarization has complex effects on cardiac excitability (Dominguez and Fozzard, ca. 1975). Mild depolarization increases excitability by decreasing the depolarization needed to reach threshold, but stronger depolarization decreases excitability and conduction velocity by inactivating Na+-channels. Increased excitability facilitates arrhythmias arising from abnormal automaticity and triggered activity, whereas impaired conduction promotes re-entry. Impaired phase-3 repolarization caused by IK1 dysfunction could lead to excess action potential prolongation and early afterdepolarizations. Thus, IK1 abnormality can promote a wide range of arrhythmia mechanisms, any of which might be implicated in ventricular tachyarrhythmias associated with Kir2.1 dysfunction in Andersen's Syndrome [6].

Our understanding of the molecular basis of IK1 is limited. At the mRNA level, the most abundant Kir2 subunit is Kir2.1, with ventricular concentrations that are >10-fold greater than those of Kir2.2 or Kir2.3 [8]. Although Kir2.1–4 have been detected in the heart [12–17], only Kir2.1–3 appear to be expressed in cardiomyocytes, whereas Kir2.4 is found in cardiac neuronal tissue [7]. There is 78% greater abundance of Kir2.1 protein in ventricle versus atrium and 228% greater abundance of Kir2.3 in atrium versus ventricle, but the relative quantities of Kir2.1 vs. Kir2.3 protein are unknown [18]. Unitary IK1 conductances change with development, suggesting developmentally-based molecular alterations [19,20]. Four different IK1 single-channel conductances are displayed in human atrial cells, compatible with molecular heterogeneity [15]. Kir2.1 anti-sense oligonucleotides suppressed, but did not eliminate, IK1 in rat ventricular myocytes, but residual current was detected, suggesting other contributors [21]. In mice genetically engineered to lack Kir2.1 completely, IK1 is absent in the presence of physiological (4 mM) extracellular [K+] [22]. Knock-out of Kir2.2 reduces IK1 by ~50% [22]. These results suggest that Kir2.1 is a component of virtually all murine IK1 channels, whereas Kir2.2 subunits are present in about half. This possibility would be most easily explained by the formation of Kir2.1–Kir2.2 heteromers [22].

4.2 Potential role of Kir2 heteromultimers
Initial studies suggested possible co-assembly between Kir2.1 and Kir2.3 subunits, mediated by N-terminal interactions [23]. Subsequent work suggested little or no heteromultimer formation between Kir2.1 and 2.2 or 2.3, with determinants for co-assembly localized to the M2 segment and proximal C-terminus [24]. Preisig-Müller et al. recently provided extensive evidence for Kir2.1, Kir2.2 and Kir2.3 heteromultimer formation [9]. They showed that concatemers of different Kir2 subunits form functional channels, that dominant negative Kir2.1, Kir2.2 or Kir2.3 constructs suppress currents carried by wild-type subunits of each subtype upon co-injection, that Kir2.1 and Kir2.3 subunits can be co-immunoprecipitated, that cytosolic carboxy terminal domains play a key role in protein–protein interaction, and that Andersen syndrome Kir2.1 mutations have dominant-negative effects upon co-expression with Kir2.1, Kir2.2 or Kir2.3.

We have shown that Kir2.1 and 2.4 subunits co-assemble, and that Ba2+-blocking properties of co-assembled channels differ from homomeric Kir2.1 or 2.4 [10]. In fact, the Ba2+-sensitivity of Kir2.1–2.4 channels was greater than those of either Kir2.1 or 2.4 alone, suggesting that heteromeric channels are not merely an intermediate hybrid form, but may have distinct properties of their own [10]. In our study of Kir2.1–Kir2.4 interaction, as in Preisig-Müller's studies of Kir2.1, Kir2.2 and Kir2.3 interaction, currents carried by co-injected subunits behaved like channels formed by concatemers (which of necessity consist of co-assembled subunits, since the subunits are covalently linked). In the present study, currents carried by Kir2.2 co-injected with either Kir2.1 or 2.3 subunits had a Ba2+ IC50 indistinguishable from Kir2.2-subunit homomeric channels, rather than between the IC50 of Kir2.2 and the larger IC50 of Kir2.1 or Kir2.3. Moreover, the IC50 of co-injected Kir2.1/Kir2.3 is lower than for either homomeric subunit and of the same order as the IC50 for Kir2.2. This observation resembles our previous findings for Kir2.1/Kir2.4 and supports the notion of distinct properties for heteromeric Kir2 channels.

The present study is the first direct comparison between properties of currents carried by combinations of Kir2 subunits with those of native IK1. The response to Ba2+ of currents carried by all combinations of co-injected subunits was more similar to that of human IK1 in terms of sensitivity, and Kir2.1/2.2 and Kir2.1/2.3 current Ba2+ blocking kinetics were more like those of IK1, than homomeric channels. This finding supports the notion that a significant portion of IK1 may be carried by Kir2 heteromers, as initially suggested by Zaritsky et al. [22] and recently reinforced by the elegant studies of Preisig-Müller and co-workers [9].

Our results help to resolve an issue arising from a recent study that compared homomeric guinea-pig Kir2 subunits to guinea-pig cardiac IK1 [7]. Based upon Ba2+-blocking properties, the authors concluded that Kir2.2 was likely the predominant subunit underlying IK1. However, in both human [8] and mouse [22] heart, Kir2.1 transcripts are much more abundant than those encoding Kir2.2. We found that Ba2+-blocking sensitivity of heteromeric Kir2 channels is similar to those of Kir2.2. Thus, the guinea-pig findings [7] are compatible with a prominent role for heteromeric Kir2 channels in native IK1, and do not necessarily imply predominance of Kir2.2 per se. This notion would fit well with results of Kir2.1 knock-down [21] and knock-out [22] studies, while being agreeing with the guinea-pig Ba2+-sensitivity data [7].

4.3 Potential limitations
We did not study single-channel Kir2 or IK1 properties. Single-channel studies of native IK1 have provided a wide variety of results. Wible et al. described four distinct conductances (41, 35, 21 and 9 pS) in human atrium [15], whereas Liu et al. found only three conductances (10.5, 22 and 32.5 pS) in guinea-pig cardiomyocytes [7]. Nakamura et al. described six diverse conductances (8, 14, 21, 35, 43 and 80 pS) in rat ventricle [21]. Conductances of native IK1 channels may differ from those of heterologously-expressed Kir2 subunits of the same species [7]. Furthermore, homomeric mouse Kir2.1 channels show a broad range of conductances ranging from 2 to 33 pS [25]. Thus, single-channel analyses have not to date provided clear insights into the molecular composition of IK1 channels.


    5. Conclusions
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
This is the first study to compare properties of heteromeric Kir2 currents with those of native cardiac IK1. Our results support the notion that a substantial proportion of native IK1 may result from heteromultimer formation among Kir2 subunits.

Time for primary review 35 days.


    Acknowledgements
 
The authors thank Chantal St-Cyr, Evelyn Landry, and Xiao Fan Yang for excellent technical assistance, and Daniela Giuliani, France Thériault and Diane Campeau for secretarial help with the manuscript. They thank Lily Jan for providing Kir2.1, Barbara Wible for Kir2.2, and Carol Vandenberg for Kir2.3. Dr Schram was supported by the Ernst and Berta Grimmke Foundation, the Canadian Institutes of Health Research (CIHR) and Aventis Pharma. Marc Pourrier was supported by a Heart and Stroke Foundation of Canada studentship. Zhiguo Wang and Michel White are research scholars of the Fonds de la recherche en santé du Québec. Operating support was received from CIHR, the Quebec Heart and Stroke Foundation, and the Mathematics of Information Technology And Complex Systems (MITACS) Network.


    References
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 

  1. Katz B. Les constantes électrique de la membrane du muscle. Arch Sci Physiol (1949) 3:285–299.
  2. Nichols C.G., Lopatin A.N. Inward rectifier potassium channels. Annu Rev Physiol (1997) 59:171–191.[CrossRef][Web of Science][Medline]
  3. Sakmann B., Trube G. Conductance properties of single inwardly rectifying potassium channels in ventricular cells from guinea-pig heart. J Physiol (Lond) (1984) 347:641–657.[Abstract/Free Full Text]
  4. Ibarra J., Morley G.E., Delmar M. Dynamics of the inward rectifier K+ current during the action potential of guinea pig ventricular myocytes. Biophys J (1991) 60:1534–1539.[Web of Science][Medline]
  5. Shimoni Y., Clark R.B., Giles W.R. Role of an inwardly rectifying potassium current in rabbit ventricular action potential. J Physiol (Lond) (1992) 448:709–727.[Abstract/Free Full Text]
  6. Plaster N.M., Tawil R., Tristani-Firouzi M., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 105:511–519.[CrossRef][Web of Science][Medline]
  7. Liu G.X., Derst C., Schlichthorl G., et al. Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea-pig cardiomyocytes. J Physiol (Lond) (2001) 532:115–126.[Abstract/Free Full Text]
  8. Wang Z., Yue L., White M., Pelletier G., Nattel S. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation (1998) 98:2422–2428.[Abstract/Free Full Text]
  9. Preisig-Muller R., Schlichthorl G., George T., et al. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci USA (2002) 99:7774–7779.[Abstract/Free Full Text]
  10. Schram G., Melnyk P., Pourrier M., Wang Z., Nattel S. Kir2.4 and Kir2.1 K+ channel subunits co-assemble: a potential new contributor to inward rectifier current heterogeneity. J Physiol (Lond) (2002) 544(2):337–349.[Abstract/Free Full Text]
  11. Lopatin A.N., Nichols C.G. Inward rectifiers in the heart: an update on I(K1). J Mol Cell Cardiol (2001) 33:625–638.[CrossRef][Web of Science][Medline]
  12. Ishii K., Yamagishi T., Taira N. Cloning and functional expression of a cardiac inward rectifier K+ channel. FEBS Lett (1994) 338:107–111.[CrossRef][Web of Science][Medline]
  13. Raab-Graham K.F., Radeke C.M., Vandenberg C.A. Molecular cloning and expression of a human heart inward rectifier potassium channel. NeuroReport (1994) 5:2501–2555.[Web of Science][Medline]
  14. Ashen M.D., O'Rourke B., Kluge K.A., Johns D.C., Tomaselli G.F. Inward rectifier K+ channel from human heart and brain: cloning and stable expression in a human cell line. Am J Physiol (Heart Circ Physiol) (1995) 268:H506–H511.[Abstract/Free Full Text]
  15. Wible B.A., De Biasi M., Majumder K., Taglialatela M., Brown A.M. Cloning and functional expression of an inwardly rectifying K+ channel from human atrium. Circ Res (1995) 76:343–500.[Abstract/Free Full Text]
  16. Wood L.S., Tsai T.D., Lee K.S., Vogeli G. Cloning and functional expression of a human gene, hIRK1, encoding the heart inward rectifier K+-channel. Gene (1995) 163:313–317.[CrossRef][Web of Science][Medline]
  17. Topert C., Doring F., Wischmeyer E., et al. Kir2.4: a novel K+ inward rectifier channel associated with motoneurons of cranial nerve nuclei. J Neurosci (1998) 18:4096–4105.[Abstract/Free Full Text]
  18. Melnyk P., Zhang L., Shrier A., Nattel S. Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle. Am J Physiol (Heart Circ Physiol) (2002) 283:H1123–H1133.[Abstract/Free Full Text]
  19. Josephson I.R., Sperelakis N. Developmental increases in the inwardly-rectifying K+ current of embryonic chick ventricular myocytes. Biochim Biophys Acta (1990) 1052:123–127.[Medline]
  20. Wahler G.M. Developmental increases in the inwardly rectifying potassium current of rat ventricular myocytes. Am J Physiol (1992) 262:C1266–C1272.[Web of Science][Medline]
  21. Nakamura T.Y., Artman M., Rudy B., Coetzee W.A. Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA. Am J Physiol (1998) 274:H892–H900.[Web of Science][Medline]
  22. Zaritsky J.J., Redell J.B., Tempel B.L., Schwarz T.L. The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol (Lond) (2001) 533:697–710.[Abstract/Free Full Text]
  23. Fink M., Duprat F., Heurteaux C., et al. Dominant negative chimeras provide evidence for homo and heteromultimeric assembly of inward rectifier K+ channel proteins via their N-terminal end. FEBS Lett (1996) 378:64–68.[CrossRef][Web of Science][Medline]
  24. Tinker A., Jan Y.N., Jan L.Y. Regions responsible for the assembly of inwardly rectifying potassium channels. Cell (1996) 87:857–868.[CrossRef][Web of Science][Medline]
  25. Picones A., Keung E., Timpe L.C. Unitary conductance variation in Kir2.1 and in cardiac inward rectifier potassium channels. Biophys J (2001) 81:2035–2049.[Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
H.-A. Lee, K.-S. Kim, S.-J. Park, and E.-J. Kim
Cellular Mechanism of the QT Prolongation Induced by Sulpiride
International Journal of Toxicology, May 1, 2009; 28(3): 207 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Maeda, E. Tanaka, K. Shoudai, K. Nonaka, N. Murayama, Y. Ito, and N. Akaike
Differential Effects of Divalent Cations on Spontaneous and Evoked Glycine Release From Spinal Interneurons
J Neurophysiol, February 1, 2009; 101(2): 1103 - 1113.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. D. Smith, S. E. Brett, K. D. Luykenaar, S. L. Sandow, S. P. Marrelli, E. J. Vigmond, and D. G. Welsh
KIR channels function as electrical amplifiers in rat vascular smooth muscle
J. Physiol., February 15, 2008; 586(4): 1147 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. K. Panama, M. McLerie, and A. N. Lopatin
Heterogeneity of IK1 in the mouse heart
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3558 - H3567.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. R. Kasten, B. Rudy, and M. P. Anderson
Differential regulation of action potential firing in adult murine thalamocortical neurons by Kv3.2, Kv1, and SK potassium and N-type calcium channels
J. Physiol., October 15, 2007; 584(2): 565 - 582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Hassinen, V. Paajanen, J. Haverinen, H. Eronen, and M. Vornanen
Cloning and expression of cardiac Kir2.1 and Kir2.2 channels in thermally acclimated rainbow trout
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2328 - R2339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. Jantzi, S. E. Brett, W. F. Jackson, R. Corteling, E. J. Vigmond, and D. G. Welsh
Inward rectifying potassium channels facilitate cell-to-cell communication in hamster retractor muscle feed arteries
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1319 - H1328.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. K. Panama and A. N. Lopatin
Differential polyamine sensitivity in inwardly rectifying Kir2 potassium channels
J. Physiol., March 1, 2006; 571(2): 287 - 302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Fang, G. Schram, V. G. Romanenko, C. Shi, L. Conti, C. A. Vandenberg, P. F. Davies, S. Nattel, and I. Levitan
Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1134 - C1144.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D.-H. Yan, K. Nishimura, K. Yoshida, K. Nakahira, T. Ehara, K. Igarashi, and K. Ishihara
Different intracellular polyamine concentrations underlie the difference in the inward rectifier K+ currents in atria and ventricles of the guinea-pig heart
J. Physiol., March 15, 2005; 563(3): 713 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Goto, N. M Rummery, T. H. Grayson, and C. E Hill
Attenuation of conducted vasodilatation in rat mesenteric arteries during hypertension: role of inwardly rectifying potassium channels
J. Physiol., November 15, 2004; 561(1): 215 - 231.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Zitron, C. Kiesecker, S. Luck, S. Kathofer, D. Thomas, V. A.W Kreye, J. Kiehn, H. A Katus, W. Schoels, and C. A Karle
Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A
Cardiovasc Res, August 15, 2004; 63(3): 520 - 527.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. S. Dhamoon, S. V. Pandit, F. Sarmast, K. R. Parisian, P. Guha, Y. Li, S. Bagwe, S. M. Taffet, and J. M.B. Anumonwo
Unique Kir2.x Properties Determine Regional and Species Differences in the Cardiac Inward Rectifier K+ Current
Circ. Res., May 28, 2004; 94(10): 1332 - 1339.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schram, G.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schram, G.
Right arrow Articles by Nattel, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?